Apoptosis, necrosis, and necroptosis in the gut and intestinal homeostasis

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Negroni, Anna ^a   Cucchiara, Salvatore ^b   Stronati, Laura ^a  

^a ENEA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CHEMOKINE; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; PHOSPHOLIPASE; PROTEINASE; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

APOPTOSIS; AUTOPHAGY; CELL AGING, CELL DEGENERATION AND CELL SURVIVAL; CELL DEATH; DNA DAMAGE; ENDOPLASMIC RETICULUM STRESS; ENTERITIS; HEAT SHOCK; HOMEOSTASIS; INTESTINE EPITHELIUM CELL; NECROPTOSIS; NECROSIS; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; PYROPTOSIS; REVIEW; ANIMAL; CYTOLOGY; HUMAN; INNATE IMMUNITY; INTESTINE; INTESTINE MUCOSA; METABOLISM; PHYSIOLOGY;

ANIMALS; APOPTOSIS; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; INTESTINAL MUCOSA; INTESTINES; NECROSIS;

EID: 84943386693     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/250762     Document Type: Review

References (130)

1. K. J. Maloy and F. Powrie. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature, vol. 474, no. 7351, pp. 298-306, 2011
2. W. S. Garrett, J. I. Gordon, and L. H. Glimcher. Homeostasis and inflammation in the intestine. Cell, vol. 140, no. 6, pp. 859-870, 2010
3. L. W. Peterson and D. Artis. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nature Reviews Immunology, vol. 14, no. 3, pp. 141-153, 2014
4. D. Artis. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nature Reviews Immunology, vol. 8, no. 6, pp. 411-420, 2008
5. E. Cario. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflammatory Bowel Diseases, vol. 16, no. 9, pp. 1583-1597, 2010
6. W. Strober, P. J. Murray, A. Kitani, and T. Watanabe. Signalling pathways and molecular interactions of NOD1 and NOD2. Nature Reviews Immunology, vol. 6, no. 1, pp. 9-20, 2006
7. R. D. SpecianandM. G. Oliver. Functional biology of intestinal goblet cells, "The American Journal of Physiology-Cell Physiology, vol. 260, no. 2, pp. C183-C193, 1991
8. T. Sato, J. H. van Es, H. J. Snippert et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature, vol. 469, no. 7330, pp. 415-418, 2011
9. M. T. Abreu. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nature Reviews Immunology, vol. 10, no. 2, pp. 131-144, 2010
10. E. Elinav, J. Henao-Mejia, and R. A. Flavell. Integrative inflammasome activity in the regulation of intestinalmucosal immune responses. Mucosal Immunology, vol. 6, no. 1, pp. 4-13, 2013
11. G.Y. Chen andG.Nez. Inflammasomes in intestinal inflammation and cancer. Gastroenterology, vol. 141, no. 6, pp. 1986-1999, 2011
12. A. H. Broquet, Y. Hirata, C. S. McAllister, and M. F. Kagnoff. RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium. The Journal of Immunology, vol. 186, no. 3, pp. 1618-1626, 2011
13. J. M. Blander. A long-Awaited merger of the pathways mediating host defence and programmed cell death. Nature Reviews Immunology, vol. 14, no. 9, pp. 601-618, 2014
14. T. T. MacDonald, I. Monteleone, M. C. Fantini, and G. Monteleone. Regulation of homeostasis and inflammation in the intestine. Gastroenterology, vol. 140, no. 6, pp. 1768-1775, 2011
15. C. S. Potten, R. Gandara, Y. R. Mahida, M. Loeffler, and N. A. Wright. The stem cells of small intestinal crypts: where are they?" Cell Proliferation, vol. 42, no. 6, pp. 731-750, 2009
16. K. L. Edelblum, F. Yan, T. Yamaoka, and D. B. Polk. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflammatory BowelDiseases, vol. 12, no. 5, pp.413-424, 2006
17. A. Strasser and M. Pellegrini. T-lymphocyte death during shutdown of an immune response. Trends in Immunology, vol. 25, no. 11, pp. 610-615, 2004
18. L. G. Van der Flier and H. Clevers. Stemcells, self-renewal, and differentiation in the intestinal epithelium. Annual Review of Physiology, vol. 71, pp. 241-260, 2009
19. C. Crosnier, D. Stamataki, and J. Lewis. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nature Reviews Genetics, vol. 7, no. 5, pp. 349-359, 2006
20. S. Y. Proskuryakov, A. G. Konoplyannikov, and V. L. Gabai. Necrosis: a specific form of programmed cell death?" Experimental Cell Research, vol. 283, no. 1, pp. 1-16, 2003
21. N. Vanlangenakker, T. VandenBerghe, D.V. Krysko, N. Festjens, and P. Vandenabeele. Molecular mechanisms and pathophysiology of necrotic cell death. Current Molecular Medicine, vol. 8, no. 3, pp. 207-220, 2008
22. R.C. Taylor, S. P. Cullen, and S. J. Martin. Apoptosis: controlled demolition at the cellular level. Nature Reviews Molecular Cell Biology, vol. 9, no. 3, pp. 231-241, 2008
23. C. Günther, H. Neumann, M. F. Neurath, and C. Becker. Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium. Gut, vol. 62, no. 7, pp. 1062-1071, 2013
24. S. W. G. Tait, G. Ichim, and D. R. Green. Die another way-non-Apoptotic mechanisms of cell death. Journal of Cell Science, vol. 127, no. 10, pp. 2135-2144, 2014
25. T. V. Berghe, A. Linkermann, S. Jouan-Lanhouet, H. Walczak, and P. Vandenabeele. Regulated necrosis: the expanding network of non-Apoptotic cell death pathways. Nature Reviews Molecular Cell Biology, vol. 15, no. 2, pp. 135-147, 2014
26. P. Vandenabeele, L. Galluzzi, T. V. Berghe, and G. Kroemer. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nature ReviewsMolecular Cell Biology, vol. 11, no. 10, pp. 700-714, 2010
27. M. Pasparakis. Necroptosis and its role in inflammation. Nature, vol. 517, no. 7534, pp. 311-320, 2015
28. M. Dagenais, T. Douglas, and M. Saleh. Role of programmed necrosis and cell death in intestinal inflammation. Current Opinion in Gastroenterology, vol. 30, no. 6, pp. 566-575, 2014
29. C. Becker, A. J. Watson, and M. F. Neurath. Complex roles of caspases in the pathogenesis of inflammatory bowel disease. Gastroenterology, vol. 144, no. 2, pp. 283-293, 2013
30. K. Bertrand. Survival of exfoliated epithelial cells: a delicate balance between anoikis and apoptosis. Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 534139, 9 pages, 2011
31. J. Yuan and G. Kroemer. Alternative cell death mechanisms in development and beyond. Genes and Development, vol. 24, no. 23, pp. 2592-2602, 2010
32. A. J. M. Watson, C. A. Duckworth, Y. Guan, and M. H. Montrose. Mechanisms of epithelial cell shedding in the mammalian intestine and maintenance of barrier function. Annals of theNew York Academy of Sciences, vol. 1165, pp. 135-142, 2009
33. P.A. Hall, P. J. Coates, B. Ansari, andD.Hopwood. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. Journal of Cell Science, vol. 107, no. 12, pp. 3569-3577, 1994
34. T. F. Bullen, S. Forrest, F. Campbell et al. Characterization of epithelial cell shedding fromhuman small intestine. Laboratory Investigation, vol. 86, no. 10, pp. 1052-1063, 2006
35. A. M. Marchiando, L. Shen, W. V. Graham et al. The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. Gastroenterology, vol. 140, no. 4, pp. 1208-1218, 2011
36. C. Günther, B. Buchen, G. He et al. Caspase-8 controls the gut response to microbial challenges by Tnf-α-dependent and independent pathways. Gut, vol. 64, no. 4, pp. 601-610, 2015
37. C. Günther, E. Martini, N. Wittkopf et al. Caspase-8 regulates TNF-Alpha-induced epithelial necroptosis and terminal ileitis. Nature, vol. 477, no. 7364, pp. 335-339, 2011
38. P.-S.Welz, A. Wullaert, K. Vlantis et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature, vol. 477, no. 7364, pp. 330-334, 2011
39. Y. Matsuoka and Y. Tsujimoto. Role of RIP1 in physiological enterocyte turnover in mouse small intestine via nonapoptotic death. Genes to Cells, vol. 20, no. 1, pp. 11-28, 2015
40. J. A. Rickard, J. A. O'Donnell, J. M. Evans et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell, vol. 157, no. 5, pp. 1175-1188, 2014
41. M. Dannappel, K. Vlantis, S. Kumari et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature, vol. 513, no. 7516, pp. 90-94, 2014
42. K. Newton, D. L. Dugger, K. E. Wickliffe et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science, vol. 343, no. 6177, pp. 1357-1360, 2014
43. G. T. Eisenhoffer, P. D. Loftus, M. Yoshigi et al. Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia. Nature, vol. 484, no. 7395, pp. 546-549, 2012
44. K. H. Vousden and X. Lu. Live or let die: the cell's response to p53. Nature Reviews Cancer, vol. 2, no. 8, pp. 594-604, 2002
45. A. J. Merritt, C. S. Potten, A. J. M. Watson et al. Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. Journal of Cell Science, vol. 108, no. 6, pp. 2261-2271, 1995
46. A. G. Renehan, S. P. Bach, and C. S. Potten. The relevance of apoptosis for cellular homeostasis and tumorigenesis in the intestine. Canadian Journal of Gastroenterology, vol. 15, no. 3, pp. 166-176, 2001
47. K. Nakayama, I. Negishi, K. Kuida, K.-I. Nakayama, H. Sawa, and D. Y. Loh. Targeted disruption of Bcl-2alpha beta in 8 Mediators of Inflammation mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 9, pp. 3700-3704, 1994
48. C. M. Knudson, K. S. K. Tung, W.G. Tourtellotte, G. A. J. Brown, and S. J. Korsmeyer. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science, vol. 270, no. 5233, pp. 96-99, 1995
49. A. Canbay, A. E. Feldstein, H. Higuchi et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology, vol. 38, no. 5, pp. 1188-1198, 2003
50. S. El Andaloussi, I. Mäger, X. O. Breakefield, and M. J. A. Wood. Extracellular vesicles: biology and emerging therapeutic opportunities. Nature Reviews Drug Discovery, vol. 12, no. 5, pp. 347-357, 2013
51. Y. Fuchs and H. Steller. Programmed cell death in animal development and disease. Cell, vol. 147, no. 4, pp. 742-758, 2011
52. A. Nenci, C. Becker, A. Wullaert et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature, vol. 446, no. 7135, pp. 557-561, 2007
53. M. Pasparakis. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nature Reviews Immunology, vol. 9, no. 11, pp. 778-788, 2009
54. R. Kajino-Sakamoto, M. Inagaki, E. Lippert et al. Enterocytederived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis. Journal of Immunology, vol. 181, no. 2, pp. 1143-1152, 2008
55. K. A. Steinbrecher, E. Harmel-Laws, R. Sitcheran, and A. S. Baldwin. Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation. The Journal of Immunology, vol. 180, no. 4, pp. 2588-2599, 2008
56. J. Bollrath, T. J. Phesse, V. A. von Burstin et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-Associated tumorigenesis. Cancer Cell, vol. 15, no. 2, pp. 91-102, 2009
57. A. Kaser, A.-H. Lee, A. Franke et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell, vol. 134, no. 5, pp. 743-756, 2008
58. R. Kiesslich, C. A. Duckworth, D. Moussata et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut, vol. 61, no. 8, pp. 1146-1153, 2012
59. C. Hagiwara, M. Tanaka, and H. Kudo. Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery. Journal of Gastroenterology and Hepatology, vol. 17, no. 7, pp. 758-764, 2002
60. S. Zeissig, C. Bojarski, N. Buergel et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor antibody treatment. Gut, vol. 53, no. 9, pp. 1295-1302, 2004
61. A. Di Sabatino, R. Ciccocioppo, O. Luinetti et al. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Diseases of the Colon and Rectum, vol. 46, no. 11, pp. 1498-1507, 2003
62. M. Boirivant, M. Marini, G. Di Felice et al. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology, vol. 116, no. 3, pp. 557-565, 1999
63. K. Ina, J. Itoh, K. Fukushima et al. ResistanceofCrohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Baxmucosal imbalance, "The Journal of Immunology, vol. 163, no. 2, pp. 1081-1090, 1999
64. I. Monteleone, G. Monteleone, D. Fina et al. A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis. Gastroenterology, vol. 130, no. 2, pp. 389-397, 2006
65. A. Ramachandran, M. Madesh, and K. A. Balasubramanian. Apoptosis in the intestinal epithelium: its relevance in normal and pathophysiological conditions. Journal of Gastroenterology and Hepatology, vol. 15, no. 2, pp. 109-120, 2000
66. S. E. Winter and A. J. Bäumler. Salmonella exploits suicidal behavior of epithelial cells. Frontiers in Microbiology, vol. 2, article 48, 2011
67. L. A. Knodler, B. A. Vallance, J. Celli et al. Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia. Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 41, pp. 17733-17738, 2010
68. N. K. Chokshi, Y. S. Guner, C. J. Hunter, J. S. Upperman, A. Grishin, and H. R. Ford The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis. Seminars in Perinatology, vol. 32, no. 2, pp. 92-99, 2008
69. N. Vanlangenakker, T. Vanden Berghe, and P. Vandenabeele. Many stimuli pull the necrotic trigger: an overview. Cell Death and Differentiation, vol. 19, no. 1, pp. 75-86, 2012
70. P. Golstein and G. Kroemer. Cell death by necrosis: towards a molecular definition. Trends in Biochemical Sciences, vol. 32, no. 1, pp. 37-43, 2007
71. N. Festjens, T. Vanden Berghe, and P. Vandenabeele. Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochimica et Biophysica Acta, vol. 1757, no. 9-10, pp. 1371-1387, 2006
72. S. Y. Proskuryakov and V. L. Gabai. Mechanisms of tumor cell necrosis. Current Pharmaceutical Design, vol. 16, no. 1, pp. 56-68, 2010
73. R. R. Dourmashkin, H. Davies, C. Wells et al. Epithelial patchy necrosis in Crohn's disease. Human Pathology, vol. 14, no. 7, pp. 643-648, 1983
74. D. H. Barkla and P. R. Gibson. The fate of epithelial cells in the human large intestine. Pathology, vol. 31, no. 3, pp. 230-238, 1999
75. K. Lewin. The Paneth cell in disease. Gut, vol. 10, no. 10, pp. 804-811, 1969
76. M. François, V. Le Cabec, M.-A. Dupont, P. J. Sansonetti, and I. Maridonneau-Parini. Induction of necrosis in human neutrophils by Shigella flexneri requires type III secretion, IpaB and IpaC invasins, and actin polymerization. Infection and Immunity, vol. 68, no. 3, pp. 1289-1296, 2000
77. H.-G. Jeong and K. J. F. Satchell. Additive function of Vibrio vulnificusMARTXVv and VvhA cytolysins promotes rapid growth and epithelial tissue necrosis during intestinal infection. PLoS Pathogens, vol. 8, no. 3, Article IDe1002581, 13pages, 2012
78. D. E. Christofferson and J. Yuan. Necroptosis as an alternative form of programmed cell death. Current Opinion in Cell Biology, vol. 22, no. 2, pp. 263-268, 2010
79. J. Han, C.-Q. Zhong, andD.-W. Zhang. Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nature Immunology, vol. 12, no. 12, pp. 1143-1149, 2011.Mediators of Inflammation 9
80. T. V. Berghe, N. Vanlangenakker, E. Parthoens et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death and Differentiation, vol. 17, no. 6, pp. 922-930, 2010
81. H. Kono and K. L. Rock. How dying cells alert the immune system to danger. Nature Reviews Immunology, vol. 8, no. 4, pp. 279-289, 2008
82. S. He, L. Wang, L. Miao et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α Cell, vol. 137, no. 6, pp. 1100-1111, 2009
83. S. He, Y. Liang, F. Shao, and X. Wang. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 50, pp. 20054-20059, 2011
84. D.-W. Zhang, J. Shao, J. Lin et al. RIP3, an energymetabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science, vol. 325, no. 5938, pp. 332-336, 2009
85. P. Vandenabeele, W. Declercq, F. Van Herreweghe, and T. Vanden Berghe. The role of the kinases RIP1 and RIP3 in TNFinduced necrosis. Science Signaling, vol. 3, no. 115, pp. 3115-3124, 2010
86. C. Günther, B. Buchen, G.W. He et al. Caspase-8 controls the gut response to microbial challenges by Tnf-α-dependent and independent pathways. Gut, vol. 64, no. 4, pp. 601-610, 2015
87. O. Micheau and J. Tschopp. Induction of TNF receptor Imediated apoptosis via two sequential signaling complexes. Cell, vol. 114, no. 2, pp. 181-190, 2003
88. H. Wang, L. Sun, L. Su et al. Mixed lineage kinase domainlike protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3, "Molecular Cell, vol. 54, no. 1, pp. 133-146, 2014
89. Z. Zhou, V. Han, and J. Han. New components of the necroptotic pathway. Protein and Cell, vol. 3, no. 11, pp. 811-817, 2012
90. J. Li, T. McQuade, A. B. Siemer et al. TheRIP1/RIP3necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell, vol. 150, no. 2, pp. 339-350, 2012
91. J. Zhao, S. Jitkaew, Z. Cai et al. Mixed lineage kinase domainlike is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 14, pp. 5322-5327, 2012
92. L. Sun, H. Wang, Z. Wang et al. Mixed lineage kinase domainlike protein mediates necrosis signaling downstream of RIP3 kinase. Cell, vol. 148, no. 1-2, pp. 213-227, 2012
93. Y. Dondelinger, W. Declercq, S. Montessuit et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Reports, vol. 7, no. 4, pp. 971-981, 2014
94. J. M. Murphy, P. E. Czabotar, J. M. Hildebrand et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity, vol. 39, no. 3, pp. 443-453, 2013
95. Z. Cai, S. Jitkaew, J. Zhao et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nature Cell Biology, vol. 16, no. 1, pp. 55-65, 2014
96. J. M. Hildebrand, M. C. Tanzer, I. S. Lucet et al. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 42, pp. 15072-15077, 2014
97. W. J. Kaiser, J. W. Upton, A. B. Long et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature, vol. 471, no. 7338, pp. 368-372, 2011
98. A. Polykratis, N. Hermance, M. Zelic et al. Cutting edge: RIPK1 kinase inactive mice are viable and protected fromTNFInduced necroptosis in vivo. The Journal of Immunology, vol. 193, no. 4, pp. 1539-1543, 2014
99. A. Kaczmarek, P. Vandenabeele, andD.V.Krysko. Necroptosis: the release of damage-Associated molecular patterns and its physiological relevance. Immunity, vol. 38, no. 2, pp. 209-223, 2013
100. W. Zhou and J. Yuan. Necroptosis in health and diseases. Seminars in Cell and Developmental Biology, vol. 35, pp. 14-23, 2014
101. C. Günther, B. Buchen, M. F. Neurath, and C. Becker. Regulation and pathophysiological role of epithelial turnover in the gut. Seminars in Cell and Developmental Biology, vol. 35, pp. 40-50, 2014
102. M. Pasparakis and P. Vandenabeele. Necroptosis and its role in inflammation. Nature, vol. 517, no. 7534, pp. 311-320, 2015
103. M. Pierdomenico, A. Negroni, L. Stronati et al. Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation. The American Journal of Gastroenterology, vol. 109, no. 2, pp. 279-287, 2014
104. M. A. Brennan and B. T. Cookson. Salmonella induces macrophage death by caspase-1-dependent necrosis, "Molecular Microbiology, vol. 38, no. 1, pp. 31-40, 2000
105. K. E. Lawlor, N. Khan, A. Mildenhall et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nature Communications, vol. 6, article 6282, 2015
106. V. A. K. Rathinam, S. K. Vanaja, and K. A. Fitzgerald. Regulation of inflammasome signaling. Nature Immunology, vol. 13, no. 4, pp. 333-342, 2012
107. E. A. Miao, J. V. Rajan, and A. Aderem. Caspase-1-induced pyroptotic cell death. Immunological Reviews, vol. 243, no. 1, pp. 206-214, 2011
108. T. Bergsbaken, S. L. Fink, and B. T. Cookson. Pyroptosis: host cell death and inflammation. Nature ReviewsMicrobiology, vol. 7, no. 2, pp. 99-109, 2009
109. P. Broz and D. M. Monack. Noncanonical inflammasomes: caspase-11 activation and effector mechanisms. PLoS Pathogens, vol. 9, no. 2, Article ID e1003144, 2013
110. M. Lamkanfi and V. M. Dixit. Mechanisms and functions of inflammasomes. Cell, vol. 157, no. 5, pp. 1013-1022, 2014
111. T.-B. Kang, S.-H. Yang, B. Toth, A. Kovalenko, and D. Wallach. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity, vol. 38, no. 1, pp. 27-40, 2013
112. F. S. Sutterwala, S. Haasken, and S. L. Cassel. Mechanism of NLRP3 inflammasome activation. Annals of the New York Academy of Sciences, vol. 1319, no. 1, pp. 82-95, 2014
113. B. Ey, A. Eyking, M. Klepak et al. Loss of TLR2 worsens spontaneous colitis inMDR1A deficiency through commensally induced pyroptosis. Journal of Immunology, vol. 190, no. 11, pp. 5676-5688, 2013
114. S. L. Fink and B. T. Cookson. Pyroptosis and host cell death responses during Salmonella infection. Cellular Microbiology, vol. 9, no. 11, pp. 2562-2570, 2007
115. T. Fernandes-Alnemri, J. Wu, J.-W. Yu et al. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death and Differentiation, vol. 14, no. 9, pp. 1590-1604, 2007. 10 Mediators of Inflammation
116. E. Elinav, T. Strowig, A. L. Kau et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell, vol. 145, no. 5, pp. 745-757, 2011
117. J. Dupaul-Chicoine, G. Yeretssian, K. Doiron et al. Control of intestinal homeostasis, colitis, and colitis-Associated colorectal cancer by the inflammatory caspases. Immunity, vol. 32, no. 3, pp. 367-378, 2010
118. T. M. Ng and D. M. Monack. Revisiting caspase-11 function in host defense. CellHost andMicrobe, vol. 14, no. 1, pp. 9-14, 2013
119. D. Demon, A. Kuchmiy, A. Fossoul, Q. Zhu, T.-D. Kanneganti, and M. Lamkanfi. Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis. Mucosal Immunology, vol. 7, no. 6, pp. 1480-1491, 2014
120. B. Levine and D. J. Klionsky. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Developmental Cell, vol. 6, no. 4, pp. 463-477, 2004
121. S. W. Ryter, K. Mizumura, and A. M. K. Choi. The impact of autophagy on cell deathmodalities. International Journal ofCell Biology, vol. 2014, Article ID 502676, 12 pages, 2014
122. L. Galluzzi, I. Vitale, J. M. Abrams et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 20122. Cell Death and Differentiation, vol. 19, no. 1, pp. 107-120, 2012
123. N. Mizushima, B. Levine, A. M. Cuervo, and D. J. Klionsky. Autophagy fights disease through cellular self-digestion. Nature, vol. 451, no. 7182, pp. 1069-1075, 2008
124. T. Nunes, C. Bernardazzi, and H. S. de Souza. Cell death and inflammatory bowel diseases: apoptosis, necrosis, and autophagy in the intestinal epithelium. BioMed Research International, vol. 2014, Article ID 218493, 12 pages, 2014
125. N. Mizushima and B. Levine. Autophagy in mammalian development and differentiation. Nature Cell Biology, vol. 12, no. 9, pp. 823-830, 2010
126. W. E. Dowdle, B. Nyfeler, J. Nagel et al. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nature Cell Biology, vol. 16, no. 11, pp. 1069-1079, 2014
127. J. L. Benjamin, R. Sumpter Jr., B. Levine, and L. V. Hooper. Intestinal epithelial autophagy is essential for host defense against invasive bacteria. Cell Host and Microbe, vol. 13, no. 6, pp. 723-734, 2013
128. K. Cadwell, J. Y. Liu, S. L. Brown et al. Akey role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature, vol. 456, no. 7219, pp. 259-263, 2008
129. T. Saitoh, N. Fujita, M. H. Jang et al. Lossof the autophagyprotein Atg16L1 enhances endotoxin-induced IL-1α production. Nature, vol. 456, no. 7219, pp. 264-268, 2008
130. N. Dupont, S. Jiang, M. Pilli, W. Ornatowski, D. Bhattacharya, and V. Deretic. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1α. EMBO Journal, vol. 30, no. 23, pp. 4701-4711, 2011